Clinical trial

A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

NCT00378183

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-02-01

PhasePHASE4

Study timeline

Study start (unknown)2001-02-01Date precision: month

Registry last updated2010-04-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizoaffective Disorderunresolved

Schizophreniaunresolved

Interventions

risperidoneDRUG · verified · RxNorm: risperidone

Sponsors & collaborators

Janssen, LPlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00378183 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.